$1.41
3.10% today
Nasdaq, Jul 24, 05:47 pm CET
ISIN
US1570851014
Symbol
CERS

Cerus Corporation Stock price

$1.45
+0.11 8.21% 1M
-0.40 21.62% 6M
-0.09 5.84% YTD
-0.94 39.33% 1Y
-3.90 72.90% 3Y
-5.16 78.06% 5Y
-4.04 73.59% 10Y
-4.08 73.78% 20Y
Nasdaq, Closing price Wed, Jul 23 2025
+0.02 1.40%

Key metrics

Basic
Market capitalization
$277.2m
Enterprise Value
$281.2m
Net debt
$4.1m
Cash
$80.9m
Shares outstanding
191.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.3 | 1.3
EV/Sales
1.4 | 1.3
EV/FCF
41.9
P/B
5.0
Financial Health
Equity Ratio
27.9%
Return on Equity
-37.3%
ROCE
-8.8%
ROIC
-12.8%
Debt/Equity
1.5
Financials (TTM | estimate)
Revenue
$206.8m | $218.1m
EBITDA
$-10.6m | $9.4m
EBIT
$-12.1m | $-11.1m
Net Income
$-19.0m | $-20.5m
Free Cash Flow
$6.7m
Growth (TTM | estimate)
Revenue
7.9% | 8.3%
EBITDA
50.4% | 176.1%
EBIT
49.3% | 21.9%
Net Income
40.0% | 2.2%
Free Cash Flow
118.2%
Margin (TTM | estimate)
Gross
60.6%
EBITDA
-5.1% | 4.3%
EBIT
-5.9%
Net
-9.2% | -9.4%
Free Cash Flow
3.2%
More
EPS
$-0.1
FCF per Share
$0.0
Short interest
5.5%
Employees
622
Rev per Employee
$320.0k
Show more

Is Cerus Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Cerus Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Cerus Corporation forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a Cerus Corporation forecast:

Buy
80%
Hold
20%

Financial data from Cerus Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
207 207
8% 8%
100%
- Direct Costs 81 81
11% 11%
39%
125 125
6% 6%
61%
- Selling and Administrative Expenses 76 76
4% 4%
37%
- Research and Development Expense 61 61
6% 6%
30%
-11 -11
50% 50%
-5%
- Depreciation and Amortization 1.53 1.53
41% 41%
1%
EBIT (Operating Income) EBIT -12 -12
49% 49%
-6%
Net Profit -19 -19
40% 40%
-9%

In millions USD.

Don't miss a Thing! We will send you all news about Cerus Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cerus Corporation Stock News

Neutral
Business Wire
2 days ago
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2025 financial results will be released on Tuesday, August 5, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Company's financial results and provide a general business overview and out...
Neutral
Business Wire
3 days ago
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that it has been awarded an additional $7.2 million contract amendment by the U.S. Department of Defense (DoD) Industrial Base Analysis and Sustainment (IBAS) program for the development of lyophilized Pathogen Reduced, Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex, or ...
Neutral
Business Wire
22 days ago
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today a European regulatory update on the INTERCEPT RBC program. “We are pleased to report that the European regulatory review for INTERCEPT RBC is advancing ahead of plan and that TÜV-SÜD, our Notified Body, has completed their review of the clinical module and transferred information to the State Institute for Drug C...
More Cerus Corporation News

Company Profile

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Head office United States
CEO Obi Greenman
Employees 622
Founded 1991
Website www.cerus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today